ArticleCancer2020

Histopathology-validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo-progression in glioblastoma.

Hamed Akbari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.